The Claim

In individuals with a 5-year risk of major vascular events below 10%, a 1.0 mmol/L reduction in LDL cholesterol achieved through statin therapy is associated with an absolute reduction of approximately 11 major vascular events per 1,000 individuals over a 5-year period, and this benefit is greater than the risks of statin-induced myopathy or diabetes.

Source: The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
59score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Quantitative
1 study reviewed
In plain English

For people with a low 5-year risk of heart attacks or strokes, lowering LDL cholesterol by 1.0 mmol/L with statins reduces the number of major vascular events by about 11 per 1,000 people over five years, and this reduction in events is larger than the increase in cases of muscle damage or diabetes caused by statins.

See the scientific wording

In individuals with a 5-year risk of major vascular events below 10%, each 1.0 mmol/L reduction in LDL cholesterol with statin therapy results in an absolute reduction of approximately 11 major vascular events per 1,000 people over 5 years, a benefit that exceeds known risks of statin therapy such as myopathy or diabetes induction.

Why this might work

Lowering LDL cholesterol stops fatty deposits from building up in artery walls, makes existing deposits harder and less likely to rupture, and reduces the chance that blood clots will form on those deposits, which prevents heart attacks and strokes.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

    For every 1,000 people with low heart disease risk, taking statins to lower cholesterol by 1.0 mmol/L prevents about 11 heart attacks, strokes, or artery surgeries over 5 years—and the side effects like diabetes are very rare, so the benefits clearly outweigh the risks.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.